Key statistics
On Friday, Harvia Oyj (G1U:FRA) closed at 39.80, 19.16% above the 52 week low of 33.40 set on Sep 29, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 39.80 |
|---|---|
| High | 39.80 |
| Low | 39.80 |
| Bid | 40.30 |
| Offer | 41.60 |
| Previous close | 40.35 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 18.69m |
| Free float | 15.75m |
| P/E (TTM) | 31.57 |
| Market cap | 758.99m EUR |
| EPS (TTM) | 1.29 EUR |
| Annual div (ADY) | 0.75 EUR |
|---|---|
| Annual div yield (ADY) | 1.88% |
| Div ex-date | Oct 20 2025 |
| Div pay-date | Oct 28 2025 |
Data delayed at least 15 minutes, as of Feb 06 2026 07:18 GMT.
More ▼
Announcements
- Harvia julkaisee vuoden 2025 tilinpäätöstiedotteen torstaina 12.2.2026 noin klo 9.00
- Harvia will publish its Financial Statements Bulletin 2025 on Thursday, 12 February 2026 at around 9:00 a.m. EET
- Harvia Oyj:n nimitystoimikunnan ehdotukset varsinaiselle yhtiökokoukselle 2026
- Proposals of Harvia Plc’s Shareholders’ Nomination Board to the Annual General Meeting 2026
- Harvia Plc: Disclosure under chapter 9, section 10 of the securities market act
- Harvia Oyj: Arvopaperimarkkinalain 9 luvun 10 pykälän mukainen ilmoitus
- Harvia’s Chair of the Board of Directors changes: Catharina Stackelberg-Hammarén elected as the new Chair
- Harvian hallituksen puheenjohtaja vaihtuu: Catharina Stackelberg-Hammarén valittu uudeksi puheenjohtajaksi
- Harvia and Dr. Emilia Vuorisalmi launch brand ambassador and content partnership in North America
- Harvia ja lääkäri Emilia Vuorisalmi aloittavat brändilähettiläs- ja sisältöyhteistyön Pohjois-Amerikassa
More ▼
